Details zur Publikation

Kategorie Textpublikation
Referenztyp Zeitschriften
DOI 10.1186/1746-6148-10-122
Titel (primär) Metabolomic biomarkers correlating with hepatic lipidosis in dairy cows
Autor Imhasly, S.; Naegeli, H.; Baumann, S.; von Bergen, M.; Luch, A.; Jungnickel, H.; Potratz, S.; Gerspach, C.
Quelle BMC Veterinary Research
Erscheinungsjahr 2014
Band/Volume 10
Seite von art. 122
Sprache englisch
Keywords Biomarker; Fatty liver; Lipidosis; Metabolomics
UFZ Querschnittsthemen RU3;


Hepatic lipidosis or fatty liver disease is a major metabolic disorder of high-producing dairy cows that compromises animal performance and, hence, causes heavy economic losses worldwide. This syndrome, occurring during the critical transition from gestation to early lactation, leads to an impaired health status, decreased milk yield, reduced fertility and shortened lifetime. Because the prevailing clinical chemistry parameters indicate advanced liver damage independently of the underlying disease, currently, hepatic lipidosis can only be ascertained by liver biopsy. We hypothesized that the condition of fatty liver disease may be accompanied by an altered profile of endogenous metabolites in the blood of affected animals.


To identify potential small-molecule biomarkers as a novel diagnostic alternative, the serum samples of diseased dairy cows were subjected to a targeted metabolomics screen by triple quadrupole mass spectrometry. A subsequent multivariate test involving principal component and linear discriminant analyses yielded 29 metabolites (amino acids, phosphatidylcholines and sphingomyelines) that, in conjunction, were able to distinguish between dairy cows with no hepatic lipidosis and those displaying different stages of the disorder.


This proof-of-concept study indicates that metabolomic profiles, including both amino acids and lipids, distinguish hepatic lipidosis from other peripartal disorders and, hence, provide a promising new tool for the diagnosis of hepatic lipidosis. By generating insights into the molecular pathogenesis of hepatic lipidosis, metabolomics studies may also facilitate the prevention of this syndrome.

dauerhafte UFZ-Verlinkung
Imhasly, S., Naegeli, H., Baumann, S., von Bergen, M., Luch, A., Jungnickel, H., Potratz, S., Gerspach, C. (2014):
Metabolomic biomarkers correlating with hepatic lipidosis in dairy cows
BMC Vet. Res. 10 , art. 122 10.1186/1746-6148-10-122